THE WHO MAKES THE WEIGHT LOSS DRUG COPYRIGHT DIARIES

U.S. pharma huge copyright scrapped two experimental weight loss supplements last yr—a once-day-to-day capsule, lotiglipron, as a result of elevated liver enzymes and a 2 times-daily pill, danuglipron, because of solid Uncomfortable side effects—but CEO Albert Bourla has said the company is set to “Engage in and win” from the weight problem